Chronic inflammatory demyelinating polyradiculoneuropathy associated with multiple sclerosis

Journal of Clinical Neuromuscular Disease

Volumn 9, Issue 4, 2008, Pages 385-396

  Sharma, Khema R ^a   Saadia, Daniela ^a   Facca, Alicia G ^a   Bhatia, Rita ^a   Ayyar, D Ram ^a   Sheremata, William ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Chronic inflammatory demyelinating polyradiculopathy; Electromyographic reflexes; Intravenous immunoglobulin therapy; Multiple sclerosis

Indexed keywords

AZATHIOPRINE; BETA1A INTERFERON; CORTICOTROPIN; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; PREDNISONE; IMMUNOLOGIC FACTOR;

ACHILLES REFLEX; ADULT; AGED; ANTIGENICITY; ARTICLE; BICEPS BRACHII MUSCLE; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; CLINICAL ARTICLE; CRANIAL NERVE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; IMAGE ENHANCEMENT; IMMUNOTHERAPY; LATENT PERIOD; MALE; MULTIPLE SCLEROSIS; MUSCLE REFLEX; PARENCHYMA; PATELLA TENDON; PERIPHERAL NERVOUS SYSTEM; PERIPHERAL NEUROPATHY; POLYRADICULONEUROPATHY; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RECURRENT DISEASE; SPINAL ROOT; TENDON REFLEX; CASE REPORT; DISABILITY; ELECTROMYOGRAPHY; HOSPITALIZATION; IMMUNOLOGY; MYOTATIC REFLEX; NERVE CONDUCTION; NONPARAMETRIC TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; TIME; TREATMENT OUTCOME;

ADULT; AGED; DISABILITY EVALUATION; ELECTROMYOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEURAL CONDUCTION; PERIPHERAL NERVOUS SYSTEM; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; REFLEX, STRETCH; SEVERITY OF ILLNESS INDEX; SPINAL NERVE ROOTS; STATISTICS, NONPARAMETRIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 50349083185     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e31816f18e3     Document Type: Article

References (54)

1. Vander Meche FG, Van Doorn PA, Meulstee J, et al. Diagnostic and classification criteria for the Guillain-Barre syndrome. Eur Neurol. 2001;45:133-139.
2. Saperstein DS, Kats JS, Amato AA, et al. Clinical spectrum of chronic acquired demyelinating poly-neuropathies. Muscle Nerve. 2001;24:311-324.
3. McDonald WI, Compson A, Eden G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001; 50:121-127.
4. Zee PC, Cohen BA, Walczak T, et al. Peripheral nervous system involvement in multiple sclerosis. Neurology. 1991;41:457-460.
5. Sarova-Pinhas I, Achiron A, Gilad R, et al. Peripheral neuropathy in multiple sclerosis: a clinical and electrophysiologic study. Acta Neurol Scand. 1995; 91:234-238.
6. Ro YI, Alexander B, Oh SJ. Multiple sclerosis and hypertrophic demyelinating peripheral neuropathy. Muscle Nerve. 1983;6:312-316.
7. Mills KR, Murray NMF. Neurophysiological evaluation of associated demyelinating peripheral neuropathy and multiple sclerosis: a case report. J Neurol Neurosurg Psychiatry. 1986;49:320-323.
8. Thomas PK, Walker RW, Rudge P, et al. Chronic demyelinating peripheral neuropathy associated with multifocal central nervous system demyelin-ation. Brain. 1987;110:53-76.
9. Mendell JR, Kolkin S, Kissel JT, et al. Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneurop- athy. Neurology. 1987;37:1291-1294.
10. Rubin M, Karpati G, Carpenter S. Combined central and peripheral myelinopathy. Neurology. 1987;37: 1287-1290.
11. Arias M, Requena I, Pereiro I. Multiple sclerosis and hypertrophic demyelinating neuropathy. J Neurol Neurosurg Psychiatry. 1992;55:857. Letter.
12. DiTrapani G, Carnevale A, Cioffi RP, et al. Multiple sclerosis associated with peripheral demyelinating neuropathy. Clin Neuropathol. 1996;15:135-138.
13. Bentes C, DeCarvalho M, DeSa J, et al. Chronic steadily progressive central and peripheral predominantly motor demyelination, involving the cranial nerves, responsive to immunoglobins. Electromyogr Clin Neurophysiol. 1999;39:33-37.
14. Quan D, Pelak V, Tenabe J, et al. Spinal and cranial hypertrophic neuropathy in multiple sclerosis. Muscle Nerve. 2005;31:772-779.
15. Zephir H, Stojkovic T, DeSeze J, et al. Relapsing demyelinating disease of both central and peripheral nervous system [abstract]. Neurology. 2006; 66(Suppl. 2):A226.
16. Carpenter A, Parry G, Birnbaum G, et al. Chronic inflammatory demyelinating polyneuropathy and multiple sclerosis: are they related [abstract]. Neurology. 2006;66(Suppl 2):A225. .
17. Falcone M, Scalise A, Minisci C, et al. Spreading of autoimmunity from central to peripheral myelin: two cases of clinical association between multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. Neurol Sci. 2006;27:58-62.
18. Forrrester C, Lascelles G. Association between poly-neuritis and multiple sclerosis. J Neurol Neurosurg Psychiatry. 1979;42:864-866.
19. Lassmann H, Budka H, Schnaberth G. Inflammatory demyelinating polyradiculitis in a patient with multiple sclerosis. Arch Neurol. 1981;38:99-102.
20. Panegyres PK, Mastaglia FL. Guillain-Barre syndrome with involvement of the central and autonomic nervous system. Med J Aust. 1989;150:55-59.
21. Uncini A, Treviso M, Basciani M, et al. Associated central and peripheral demyelination: an electro-physiological study. J Neurol. 1988;235:238-240.
22. Hopf HC, Eysholdt M. Impaired refractory periods of peripheral sensory nerves in multiple sclerosis. Ann Neurol. 1978;4:499-501.
23. Weir A, Hansen S, Ballantyne P. Motor unit potential abnormalities in multiple sclerosis: further evidence for peripheral nervous system defect. J Neurol Neurosurg Psychiatry. 1980;43:999-1004.
24. Eisen A, Paty D, Hoirch M. Altered supernormality in multiple sclerosis peripheral nerve. Muscle Nerve. 1982;5:411-414.
25. Shefner J, Carter J, Krarup C. Peripheral sensory abnormalities in patients with multiple sclerosis. Muscle Nerve. 1992;15:73-76.
26. Anlar O, Tombul T, Kisli M. Peripheral sensory and motor abnormalities in patients with multiple sclerosis. Electromyogr Clin Neurophysiol. 2003; 43:349-351.
27. Pogorzelski R, Baniukiewicz E, Drozdowski W. Subclinical lesions of peripheral nervous system in multiple sclerosis patients. Neurol Neurochir Pol. 2004;38:257-264.
28. Ormerod I, Waddy H, Kermode A, et al. Involvement of the central nervous system in chronic inflammatory demyelinating polyneuropathy: a clinical electrophysiological and magnetic resonance imaging study. J Neurol Neurosurg Psychiatry. 1990;53: 789-793.
29. Feasy TE, Hahn AF, Koopman WJ, et al. Central lesions in chronic inflammatory demyelinating polyneuropathy: an MRI study. Neurology. 1990;40: 476-478.
30. Hawke S, Hallinan J, McLeod J. Cranial magnetic resonance imaging in chronic demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry. 1990; 53:794-796.
31. Hasson J, Terry RD, Zimmerman HM. Peripheral neuropathy in multiple sclerosis. Neurology. 1958;8: 503-510.
32. Schoene WC, Carpenter S, Behan P, et al. 'Onion bulb' formations in the central and peripheral nervous system in association with multiple sclerosis and hypertrophic polyneuropathy. Brain. 1977;100: 755-773.
33. Pollock M, Calder C, Allpress S. Peripheral nerve abnormality in multiple sclerosis. Ann Neurol. 1977; 2:41-48.
34. Rosenberg NL, Bourdette D. Hypertrophic neuropathy and multiple sclerosis. Neurology. 1983;33: 1361-1364.
35. Oh SJ. Clinical Electromyography: Nerve Conduction Studies. 2nd ed. Baltimore, MD: Williams and Wilkins; 1993:382-389.
36. Sharma K, Resnick S, Saadia D, et al. Diagnostic role of deep tendon reflexes in small-fiber neuropathy. JPeripher Nerv Syst. 2007;12:223-231.
37. Sharma KR, Cross J, Farronay O, et al. Demyelinating neuropathy in diabetes mellitus. Arch Neurol. 2002; 59:758-765.
38. Dyck PJ, Litchy WJ, Lehman K, et al. Variables influencing neuropathic end points: the Rochester Diabetic Neuropathy Study of Healthy Subjects. Neurology. 1995;45:1115-1121.
39. Kurtzke JF. Rating neurological impairment in multiple sclerosis; an expanded disability status scale (EDSS). Neurology. 1983;33:1444-1452.
40. Ekstein D, Linetsky E, Abramsky O, et al. Polyneuropathy associated with interferon beta treatment in patients with multiple sclerosis. Neurology. 2005;65: 456-458.
41. Meyer-Rienecker H, Buddenhagen F. Incidence of multiple sclerosis: periodic or stable phenomenon. J Neurol. 1988;235:241-244.
42. Kieseier BC, Kiefer R, Gold R, et al. Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve. 2004;30:131-156.
43. Lees MB, Brostoff SW. Proteins of myelin. In: Morell P, ed. Myelin. New York: Plum; 1984:197-224.
44. Figlewicz DA, Quarles RH, Johnson D, et al. Biochemical demonstration of the myelin-associated glycoprotein in the peripheral nervous systems. J Neurochem. 1981;37:749-758.
45. Sterberger NH, Quarles RH, Itoyama Y, et al. Myelin-associated glycoprotein demonstrated immunocyto-chemically in myelin and myelin-forming cells of developing rat. Proc Natl Acad Sci USA. 1979;76: 1510-1514.
46. Zweiman B, Moskowitz AR, Rotami A, et al. Antibodies to P1 and P2 myelin antigens in experimental allergic neuritis and allergic encephalitis. J Neuroimmunol. 1982;2:331-336.
47. Madrid RE, Wisniewski HM. Peripheral nervous system pathology in relapsing experimental allergic encephalomyelitis. J Neurocytol. 1978;7:265-282.
48. Raine CS, Wisniewski H, Dowling PC, et al. An ultrastructural study of experimental demyelin-ation and remyelination: IV. Recurrent episodes and PNS plaque formation in EAE. Lab Invest. 1971;25: 28-41.
49. Pender MP. The pathophysiology of myelin basic protein induced acute experimental allergic enceph-alomyelitis in Lewis rat. J Neurol Sci. 1988;86: 277-289.
50. Rocklin RE, Sheremata WA, Feldman RG, et al. The Guillain-Barre syndrome and multiple sclerosis: in vitro cellular response to nervous-tissue antigens. N Engl J Med. 1971;284:803-808.
51. Lucchinetti C, Brück W, Parisi J, et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 200;47: 707-717.
52. Hughes RAC, Gregson NA, Hadden RDM, et al. Pathogenesis of Guillain-Barré syndrome. J Neuro-immunol. 1999;100:74-97.
53. Miller SD, Vanderlugt CL, Begolka WS, et al. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat Med. 1997; 3:1133-1136.
54. Davies JM. Introduction: epitope mimicry as a component cause of autoimmune disease. Cell Mol Life Sci. 2000;57:523-526.